Cedarburg Pharmaceuticals is Pharmaceuticals in United States that focus on pharmaceutical intermediates business. Founded in 1998. They cover business area such as developer, commercial small molecule, active pharmaceutical ingredient, api, pharmaceutical intermediate, biotech industry, organic molecule, process development, scale, analytical method development, optimization, technology, transfer.
1998
( 26 years old in 2024 )
Pharmaceutical Intermediates
-
870 Badger Circle
Grafton, WI 53024
United States
Private
developercommercial small moleculeactive pharmaceutical ingredientapipharmaceutical intermediatebiotech industryorganic moleculeprocess developmentscaleanalytical method developmentoptimizationtechnologytransfer
* We use standard office opening hours in near Cedarburg Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cedarburg Pharmaceuticals is Pharmaceuticals business from United States that founded in 1998 (26 years old in 2024), Cedarburg Pharmaceuticals business is focusing on Pharmaceutical Intermediates.
Cedarburg Pharmaceuticals headquarter office and corporate office address is located in 870 Badger Circle Grafton, WI 53024 United States.
Cedarburg Pharmaceuticals was founded in United States.
In 2024, Cedarburg Pharmaceuticals is currently focus on pharmaceutical intermediates sector.
Above is snippet of Google Trends for "pharmaceutical intermediates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cedarburg Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
